Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

XDx

PRA picks Sean Leech to lead in Europe, Asia Pacific and Africa

His previous experience includes an eight-year spell with fellow CRO Icon

Novartis building

Gilenya cuts early relapse, brain loss in MS patients

Boosts prospects for oral drug as competitors emerge

- PMLiVE

MHRA appoints Michael Rhodes as medical director of devices

He will take over from Dr Susanne Ludgate, who is retiring in December

The CementBloc expands its team

The CementBloc announces 15 new hires for its New York office 

Harren Jhoti and Will West join BIA board

UK biotech trade body welcomes CEOs of Astex Pharmaceuticals and CellCentric

- PMLiVE

Novartis launches YouTube cancer talk show

Each Voice Counts forms part of firm’s existing advanced breast cancer initiative

Chiltern International lines up Dr Jim Esinhart as next CEO

He will replace Glenn Kerkhof from November 1, 2012

Axelar appoints Carl Harald Janson as CEO

Takes control as company prepares to take novel cancer drug to proof-of-concept

Kane & Finkel appoints John Flaherty as European director

John Flaherty has been appointed to the role of European director at Kane & Finkel Healthcare Communications

- PMLiVE

Louise Tamblin returns to Kantar Health as group director

Moves from Strata Research

Evotec CEO Werner Lanthaler temporarily stands down

Cites health reasons

- PMLiVE

NICE in U-turn on Novartis’ Lucentis in diabetic macular oedema

Patient access scheme influences draft recommendation

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links